<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000411379"><TermName>monoclonal gammopathy of undetermined significance</TermName><TermPronunciation>(MAH-noh-KLOH-nul ga-MAH-puh-thee ... UN-deh-TER-mind sig-NIH-fih-kunts)</TermPronunciation><TermDefinition><DefinitionText>A benign condition in which there is a higher-than-normal level of a protein called M protein in the blood. Patients with monoclonal gammopathy of undetermined significance are at an increased risk of developing cancer. Also called MGUS.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713319" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;monoclonal gammopathy of undetermined significance&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713318" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gammapatía monoclonal de significancia indeterminada&quot;" language="es" id="_4"/><SpanishTermName>gammapatía monoclonal de significación indeterminada</SpanishTermName><SpanishTermDefinition><DefinitionText>Afección benigna en la que hay una concentración alta de una proteína de la sangre llamada proteína M. Los pacientes de gammapatía monoclonal de importancia indeterminada tienen un riesgo más alto de padecer de cáncer También se llama GMSI.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-12-22</DateFirstPublished><DateLastModified>2007-10-01</DateLastModified></GlossaryTerm>
